The goal of this proposal is to develop a method which will increase the resistance of hematopoietic cells to agents known to be leukemogenic. Alkylating agents, in particular, nitrosoureas, cause secondary leukemias in humans and animals because of their ability to create mutagenic DNA damage. It appears that hematopoietic cells are susceptible to nitrosoureas because they contain low levels of a DNA repair enzyme which normally protects cells from the DNA damage caused by these agents. The repair enzyme, 06 alkylguanine-DNA alkyltransferase (alkyltransferase), removes 06 alkylguanine adducts which are formed by nitrosoureas and, if left unrepaired, cause mutations during DNA replication. This proposal will use molecular cloning techniques to introduce the bacterial alkyltransferase gene, ada, into hematopoietic cells and then use assays of hematopoietic stem cells and bone marrow transplantation to test the ability of ada to be expressed in hematopoietic precursors. Because high levels of ada can also confer drug resistance, these studies will evaluate a potentially new drug resistance gene that may be useful in future gene transfer experiments.
The specific aims of this proposal are: (1) Introduce ada as a chimeric gene consisting of a mammalian promoter ligated to the coding sequence of the E. coli alkyltransferase gene into a replication defective retroviral vector. This vector will be transfected into cells which can produced helper free retroviral particles containing the ada gene. (2) Use retroviral vectors containing ada to infect mouse bone marrow cells, resulting in efficient transfer of the alkyltransferase gene into hematopoietic precursors. Ada expression and nitrosourea resistance will be studied in these cells in vitro. (3) Bone marrow cells infected with defective retroviral particles containing ada will be used to transplant mice. The ability of bone marrow cells to express ada and become resistant to nitrosoureas in vivo will be determined. Finally, we will determine whether these animals are protected from the development of leukemia following nitrosourea exposure. These studies will provide evidence about the etiology of secondary leukemias.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045609-02
Application #
3188732
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1987-08-15
Project End
1990-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Gerson, S L; Berger, N A; Arce, C et al. (1992) Modulation of nitrosourea resistance in human colon cancer by O6-methylguanine. Biochem Pharmacol 43:1101-7
Ryder, J W; Lazarus, H M; Farhi, D C (1992) Bone marrow and blood findings after marrow transplantation and rhGM-CSF therapy. Am J Clin Pathol 97:631-7
Nichols, C R; Andersen, J; Lazarus, H M et al. (1992) High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 10:558-63
Liu, L; Castonguay, A; Gerson, S L (1992) Lack of correlation between DNA methylation and hepatocarcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 13:2137-40
Lazarus, H M; Andersen, J; Chen, M G et al. (1991) Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial. Blood 78:830-7
Dolan, M E; Pegg, A E; Dumenco, L L et al. (1991) Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine. Carcinogenesis 12:2305-9
Dumenco, L L; Arce, C; Norton, K et al. (1991) Enhanced repair of O6-methylguanine DNA adducts in the liver of transgenic mice expressing the ada gene. Cancer Res 51:3391-8
Clapp, D W; Dumenco, L L; Hatzoglou, M et al. (1991) Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer. Blood 78:1132-9
Lim, I K; Dumenco, L L; Yun, J et al. (1990) High level, regulated expression of the chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase (ada) gene in transgenic mice. Cancer Res 50:1701-8
Lim, I K; Dumenco, L L; Hatzoglou, M et al. (1990) Increased drug resistance following retroviral gene transfer of a chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase gene into NRK cells. Carcinogenesis 11:737-43

Showing the most recent 10 out of 13 publications